The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
CAR-T Meeting 2020 | The importance of standardized data collection of CAR T-cells therapy
Marcelo Pasquini, MD, Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, discusses the importance of standardizing registration of cellular therapies such as CAR T-cells. Data collection through a standardized approach can be used for both regulatory requirements and research as well as an important resource to the biomedical community. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
